GT Biopharma filed with the SEC regarding institutional investment, and its stock traded on the Nasdaq exchange.
5 reports, 2 independent
Updated Sun 00:00
No new developments lately
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GT Biopharma filed with the SEC regarding institutional investment, and its stock traded on the Nasdaq exchange.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Wealth Management bought GT Biopharma stock, and MarketBeat provided average rating data.1 source
GT Biopharma filed with SEC about institutional investment; stock traded on Nasdaq.1 source
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines
-
Nasdaq
American fully electronic stock exchange
Related events
- Pfizer filed with the SEC on May 27, 2026, regarding institutional share holdings and active buying/selling of stock.
- Columbia Banking System, Inc. filed required documents with the SEC and is traded on Nasdaq.
- SEC filing relates to stock traded on Nasdaq.
- Linde PLC filed reports with the Securities and Exchange Commission and was listed on the Nasdaq stock exchange.
- O’Reilly Automotive, Inc. traded on the Nasdaq exchange and filed required documents with the SEC on July 24, 2026.